mRNA |
paclitaxel |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.02 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.02 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.02 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.02 |
mRNA |
NSC-207895 |
GDSC1000 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.02 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.03 |
mRNA |
FTI-277 |
GDSC1000 |
pan-cancer |
AAC |
0.083 |
0.03 |
mRNA |
Cyclopamine |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.03 |